Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
Recruiting · NCT07008664 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2026-07-29 | NCT07008664 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| EPOCH Epigenetics, Inc | 3 |
| University of Maryland, Baltimore | 198 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Maryland Baltimore Washington Medical Center | Glen Burnie | United States | 4 |